Psychedelics – reasons for caution: Stacy Fischer, Brian Anderson, Theora Cimino
GeriPal
MARCH 9, 2023
FDA is considering approval, shifting away from Schedule I restrictions, paving the way for use in clinical practice. One of the headlines there was about a family medicine doc, not to pick on family medicine, a doc, who was prescribing mail order psychedelics at really high volumes around the country.
Let's personalize your content